ArticleBMC neurology2021

Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG study.

Karlijn Bouman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.